RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
1-Year Return
33.9%
This Quarter Return
+14.8%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.85B
AUM Growth
+$181M
(+11%)
Cap. Flow
+$33.5M
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
272
New
16
Increased
74
Reduced
154
Closed
22
Top Buys
| 1 |
WEX
WEX
|
$28.1M |
| 2 |
Amdocs
DOX
|
$11.3M |
| 3 |
Etsy
ETSY
|
$9.19M |
| 4 |
Gentex
GNTX
|
$8.47M |
| 5 |
MGP Ingredients
MGPI
|
$6.55M |
Top Sells
| 1 |
Axos Financial
AX
|
$16M |
| 2 |
ADMA Biologics
ADMA
|
$14.8M |
| 3 |
ACI Worldwide
ACIW
|
$11M |
| 4 |
Pacira BioSciences
PCRX
|
$11M |
| 5 |
RXO
RXO
|
$8.37M |
Sector Composition
| 1 | Healthcare | 30.6% |
| 2 | Technology | 28.58% |
| 3 | Industrials | 16.54% |
| 4 | Consumer Staples | 6.67% |
| 5 | Communication Services | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Mativ Holdings
MATV
$659M
| $1.96M | 0.11% |
115,136
-1,141
| -1% | -$19.4K |
|
|
SWI
177
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.95M | 0.11% |
149,245
+3,039
| +2% | +$39.7K |
|
178
Zynex
ZYXI
$45.1M
| $1.88M | 0.1% |
230,678
-2,911
| -1% | -$23.8K |
|
179
Clearfield
CLFD
$456M
| $1.83M | 0.1% |
47,043
-381
| -0.8% | -$14.8K |
|
180
STAAR Surgical
STAA
$1.38B
| $1.8M | 0.1% |
48,352
-762
| -2% | -$28.3K |
|
181
Integral Ad Science
IAS
$1.45B
| $1.79M | 0.1% |
+166,047
| New | +$1.79M |
|
182
Cisco
CSCO
$269B
| $1.79M | 0.1% |
33,557
-165
| -0.5% | -$8.78K |
|
183
Montrose Environmental
MEG
$1.03B
| $1.78M | 0.1% |
67,714
-701
| -1% | -$18.4K |
|
184
Pliant Therapeutics
PLRX
$100M
| $1.76M | 0.1% |
157,217
+29,583
| +23% | +$332K |
|
185
Grid Dynamics Holdings
GDYN
$666M
| $1.75M | 0.09% |
+125,084
| New | +$1.75M |
|
186
1-800-Flowers.com
FLWS
$329M
| $1.74M | 0.09% |
218,811
+41,737
| +24% | +$331K |
|
187
Smith-Midland
SMID
$219M
| $1.73M | 0.09% |
51,731
+9,578
| +23% | +$320K |
|
188
Rocket Pharmaceuticals
RCKT
$349M
| $1.7M | 0.09% |
92,142
+16,719
| +22% | +$309K |
|
189
Thryv Holdings
THRY
$545M
| $1.6M | 0.09% |
92,720
-586
| -0.6% | -$10.1K |
|
190
Eli Lilly
LLY
$666B
| $1.5M | 0.08% |
1,690
-150
| -8% | -$133K |
|
191
Upland Software
UPLD
$69.1M
| $1.47M | 0.08% |
589,226
+315,651
| +115% | +$786K |
|
192
Vicor
VICR
$2.33B
| $1.44M | 0.08% |
34,224
-338
| -1% | -$14.2K |
|
193
Y-mAbs Therapeutics
YMAB
$389M
| $1.43M | 0.08% |
108,684
+18,949
| +21% | +$249K |
|
194
Johnson & Johnson
JNJ
$431B
| $1.4M | 0.08% |
8,658
-114
| -1% | -$18.5K |
|
195
First Watch Restaurant Group
FWRG
$1.14B
| $1.37M | 0.07% |
87,799
+54,546
| +164% | +$851K |
|
196
DMC Global
BOOM
$143M
| $1.35M | 0.07% |
104,235
-815
| -0.8% | -$10.6K |
|
197
Xylem
XYL
$34.5B
| $1.34M | 0.07% |
9,927
-146
| -1% | -$19.7K |
|
198
Travere Therapeutics
TVTX
$1.89B
| $1.33M | 0.07% |
94,736
+18,562
| +24% | +$260K |
|
199
BWX Technologies
BWXT
$15B
| $1.31M | 0.07% |
12,012
-291
| -2% | -$31.6K |
|
200
ACM Research
ACMR
$1.73B
| $1.29M | 0.07% |
63,506
-721
| -1% | -$14.6K |
|